Characteristics of inpatients with newly diagnosed multiple myeloma in hematology, nephrology, and orthopedic departments

被引:0
作者
Zhang, Yanjie [1 ]
Pan, Juan [2 ]
Kang, Haixin [1 ]
Peng, Shuotao [1 ]
Tung, Tao-Hsin [3 ]
Shen, Bo [1 ]
机构
[1] Wenzhou Med Univ, Dept Clin Lab, Taizhou Hosp Zhejiang Prov, Linhai 317000, Peoples R China
[2] Zhejiang Univ, Taizhou Hosp, Dept Clin Lab, Linhai 317000, Peoples R China
[3] Wenzhou Med Univ, Taizhou Hosp Zhejiang Prov, Evidence Based Med Ctr, Linhai 317000, Peoples R China
关键词
Multiple myeloma; Hospital departments; Risk factors; Red blood cell count; Total protein; DELAY; BETA-2-MICROGLOBULIN;
D O I
10.1007/s00277-023-05115-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To describe the characteristics of multiple myeloma (MM) by retrospectively analyzing data from patients with MM in hematology, nephrology, and orthopedic departments, we selected inpatients diagnosed with MM for the first time who were admitted to the hematology department of Taizhou Hospital of Zhejiang Province between January 1, 2017, and June 30, 2021 ( n = 110 ) and those admitted to the nephrology ( n = 48 ) and orthopedic ( n = 42 ) departments of Taizhou Hospital of Zhejiang Province between January 1, 2010, and June 30, 2021. For patients with MM initially diagnosed in the nephrology or orthopedic departments, age-and sex-matched patients without MM were randomly selected in a 1:1 ratio. Conditional logistic regression models were used to assess the risk of MM in hospitalized patients in the nephrology and orthopedic departments. This study included 200 patients, with a median age of 65 years. There were differences among patients in the three departments with respect to fracture, degree of anemia, proteinuria levels, red blood cell (RBC) count, hemoglobin levels, total protein (TP) levels, albumin levels, and laboratory indicators of renal function. TP levels > 68.45 g/L were independent risk factors for patients in the nephrology department (odds ratio (OR) = 1.01, 95% confidence interval (CI) = 1.001-1.024, P = 0.04), and RBC count < 3.79 x 10(12)/L was an independent risk factor for orthopedic inpatients (OR = 0.49, 95% CI 0.268-0.913, P = 0.02). Therefore, nephrologists should pay attention to the TP level of hospitalized patients to facilitate the early identification of MM in patients with chronic kidney disease. Orthopedic surgeons should pay attention to RBC counts in patients with fractures, and patients with low RBC counts should avoid unnecessary surgery and move to specialist care as early as possible.
引用
收藏
页码:801 / 809
页数:9
相关论文
共 28 条
  • [1] [Anonymous], 2016, N Engl J Med, V374, P1797, DOI 10.1056/NEJMx160008
  • [2] BATAILLE R, 1992, BLOOD, V80, P733
  • [3] SERUM BETA-2-MICROGLOBULIN AND SURVIVAL DURATION IN MULTIPLE-MYELOMA - A SIMPLE RELIABLE MARKER FOR STAGING
    BATAILLE, R
    DURIE, BGM
    GRENIER, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1983, 55 (03) : 439 - 447
  • [4] Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting
    Bonello, Francesca
    Cani, Lorenzo
    D'Agostino, Mattia
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Treatment and disease-related complications in multiple myeloma: Implications for survivorship
    Chakraborty, Rajshekhar
    Majhail, Navneet S.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (06) : 672 - 690
  • [6] Chinese Hematology Association, 2022, Zhonghua Nei Ke Za Zhi, V61, P480, DOI 10.3760/cma.j.cn112138-20220309-00165
  • [7] Diagnosis and Management of Multiple Myeloma A Review
    Cowan, Andrew J.
    Green, Damian J.
    Kwok, Mary
    Lee, Sarah
    Coffey, David G.
    Holmberg, Leona A.
    Tuazon, Sherilyn
    Gopal, Ajay K.
    Libby, Edward N.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (05): : 464 - 477
  • [8] Rapid discrimination of multiple myeloma patients by artificial neural networks coupled with mass spectrometry of peripheral blood plasma
    Deulofeu, Meritxell
    Kolarova, Lenka
    Salvado, Victoria
    Maria Pena-Mendez, Eladia
    Almasi, Martina
    Stork, Martin
    Pour, Ludek
    Boadas-Vaello, Pere
    Sevcikova, Sabina
    Havel, Josef
    Vanhara, Petr
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Dimopoulos, M. A.
    Moreau, P.
    Terpos, E.
    Mateos, M., V
    Zweegman, S.
    Cook, G.
    Delforge, M.
    Hajek, R.
    Schjesvold, F.
    Cavo, M.
    Goldschmidt, H.
    Facon, T.
    Einsele, H.
    Boccadoro, M.
    San-Miguel, J.
    Sonneveld, P.
    Mey, U.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 (03) : 309 - 322
  • [10] Routine blood biomarkers for the detection of multiple myeloma using machine learning
    Fan, Gaowei
    Cui, Ruifang
    Zhang, Rui
    Zhang, Shunli
    Guo, Ruipeng
    Zhai, Yuhua
    Yue, Yuhong
    Wang, Qingtao
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2022, 44 (03) : 558 - 566